KTTA – pasithea therapeutics corp. (US:NASDAQ)
Stock Stats
News
Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer [Yahoo! Finance]
Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer
Pasithea Therapeutics files to sell 3.74M shares of common stock for holders [Seeking Alpha]
Pasithea Therapeutics Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Pasithea Therapeutics Announces Positive Initial Safety, Tolerability, Pharmacokinetic (PK), and Preliminary Efficacy Data from its Phase 1 Clinical Trial of PAS-004 in Advanced Cancer [Yahoo! Finance]
Form SC 13G Pasithea Therapeutics Filed by: ARMISTICE CAPITAL, LLC
Form 10-Q Pasithea Therapeutics For: Sep 30
Form EFFECT Pasithea Therapeutics
Form 424B3 Pasithea Therapeutics
Form S-3 Pasithea Therapeutics
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.